WCI

RI Related News

게시글 목록
No TItle Name Date Hit
712 ITM and MTTI Sign Clinical Supply Agreement for n.c.a. Lutetium-177 WCI Secretariat 2022/05/04 3125
711 ITM Announces Successful Completion of Patient Recruitment for its Phase III Trial, COMPETE, with Lead Radiotherapeutic ITM-11 (n.c.a. lutetium-177-edotreotide) WCI Secretariat 2022/05/04 3249
710 Facility for rare Isotope Beams to Open its Doors to Discovery WCI Secretariat 2022/05/04 3208
709 Plus Therapeutics and Medidata Announce Expanded Clinical Trial Partnership WCI Secretariat 2022/05/04 3112
708 Australian Prime Minister Announces Funding for Precision Medicine WCI Secretariat 2022/05/04 3230
707 Clovis Oncology Highlights Presentations On FAP-2286 And Rubraca® (Rucaparib) At The AACR Annual Meeting 2022 WCI Secretariat 2022/05/03 3265
706 Fast Electrons Accelerate the Production of Medical Isotopes WCI Secretariat 2022/05/03 3218
705 NorthStar Medical Radioisotopes provides Updates on Corporate progress and Progress and Upcoming Milestones WCI Secretariat 2022/05/03 3187
704 Novartis Pluvicto™ approved by FDA as first targeted radioligand therapy for treatment of progressive, PSMA positive metastatic castration-resistant prostate cancer WCI Secretariat 2022/04/08 3257
703 BOC Sciences Updates Product List to Expand Access to Stable Isotope-Labeled Amino Acids WCI Secretariat 2022/04/08 3335
702 POINT Biopharma Confirms No Delays to SPLASH Trial Due to Recent Global Lutetium Supply Interruption WCI Secretariat 2022/04/08 3231
701 Eckert & Ziegler to Supply Canadian Alpha-9 Theranostics with Lutetium-177 for Clinical Trials WCI Secretariat 2022/04/08 3216
700 Eckert & Ziegler Extends Supply Agreement with Sirtex Medical to Chinese Market WCI Secretariat 2022/04/08 3351
699 Telix Radiopharmaceutical Production Facility Buildout Commences WCI Secretariat 2022/04/08 3326
698 High Flux Reactor back in full operation WCI Secretariat 2022/04/08 3400

비밀글입니다!

글작성시 입력했던 비밀번호를 입력해주세요.